T2DM Therapeutics Flashcards
(68 cards)
Choice if someone has HF
sglt2 —- evidence of 2nd prevention (not primary)
Drug of choice if someone has CKD
sglt2i or GLP-1a
—- both 2nd prevention; cardio renal protective
drug of choice if someone has CVD
sglt2i or GLp-1a
T or F: if someone is a new T2DM w eGFR < 30 , its okay to start on metformin
F- avoid starting if eGFR < 30
fully CI if eGFR < 15
dose adjust once less than 45 (MDD 1000mg)
Metformin A1c lowering abilities
1-1.5%
When it metformin CI
severe renal or liver dysfunction, severe infection or dehydration, CV collapse, previous lactic acidosis
SEs of metformin
GI, metallic taste + lactic acidosis
Metformins impact on weight
neutral + low hypo risk
What vitamin can metformin impact the absorption of
B12
What should all be monitored when on metformin
A1c, SCr, Hg, and B12
Brand names of metformin
glucophage — IR
glumetza ER (may helps with Ses; take with evening meal)
What is lactic acidosis
elevation of blood lactate < 5, decreased pH, electrolyte disturbances w/ increased anion gap
—- normally happens when on metformin ++++ respiratory failure or renal insuffiency
—- accumulation of metformin ; decrease conversion of lactate to glucose — increased lactate production
** don’t know if metformin is cause or just associated
What drugs are the best options for weight loss
semaglutide (injection) or tirzepatide
other high; dulaglutide + liraglutide
mid: SGLT2, exenatide, lixisenatide
Which drugs have the highest hypo risk
premixed insulin, glinide, SU, basal insulin
Best A1C lowers w/ metformin
premixed insulin ; GLP-1a (lower by around 1)
mid: SGLT2, SU, TZDs
Which of the SGLT2i have to be dosed before 1st meal of the day
Canagliflozin
SEs of SGLT2i
volume depletion, GU infections (3-4X more likely), DKA (2X), thirst, need to pee more
T or F: don’t start an sglt2 if eFGR is less than 20
T- if already on, can leave on
Which sglt2i has an increased risk of amputations or fracture
cana
T or F: SGLT2i provide 2nd prevention for CKD, HF, and CVD
T- not primary
— only studied to show benefit in those who already have these conditions + preventing progression
What to monitor when on SGLT2i
Renal fxn, volume, A1c, DKA
MoA of SGLT2
reduce glucose reabsorption in PCT
- in T2DM: lower renal threshold for when we stop reabsorbing glucose by 4-5 mmol/L (normally stop reabsorbing at 10)
—- this counteracts this and helps us “return to normal” and stop reabsorbing glucose at normal level
Is if normal for SGLT2i to cause an initial decline in renal fxn
yes - decrease by 4-6 mL/min
—- if decreases by more than 15-20% ; stop or decrease dose
Which GLP-1a injection is given daily
liraglutide - daily injection
semaglutide + dulaglutide - weekly (D has to be at the same time)
- rybelsus: daily PO option (taken first thing in the am with water)